Matthias Schroff

878 total citations
39 papers, 685 citations indexed

About

Matthias Schroff is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Matthias Schroff has authored 39 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Matthias Schroff's work include Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (10 papers) and Cancer Research and Treatments (9 papers). Matthias Schroff is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (10 papers) and Cancer Research and Treatments (9 papers). Matthias Schroff collaborates with scholars based in Germany, United States and United Kingdom. Matthias Schroff's co-authors include Burghardt Wittig, Claas Junghans, Manuel Schmidt, Christiane Kleuss, Ingo G.H. Schmidt‐Wolf, Frank Schakowski, Marcus Gorschlüter, Tilman Sauerbruch, Carsten Ziske and Peter Buttgereit and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Matthias Schroff

35 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Schroff Germany 16 316 306 190 125 115 39 685
Mili Gu United States 10 226 0.7× 294 1.0× 135 0.7× 73 0.6× 81 0.7× 16 595
Tyler Parr United States 7 399 1.3× 323 1.1× 135 0.7× 46 0.4× 133 1.2× 13 758
Ana Lemos de Matos United States 12 189 0.6× 172 0.6× 252 1.3× 190 1.5× 88 0.8× 22 527
Hongxing Zhao Sweden 20 168 0.5× 566 1.8× 356 1.9× 87 0.7× 183 1.6× 38 957
Agnes E. Hamburger United States 13 262 0.8× 287 0.9× 46 0.2× 156 1.2× 115 1.0× 19 769
Stephen Pacchione United States 10 202 0.6× 587 1.9× 168 0.9× 96 0.8× 81 0.7× 15 831
Michael D. Eisenbraun United States 11 591 1.9× 232 0.8× 106 0.6× 84 0.7× 171 1.5× 15 874
Oliver Höhn Germany 15 348 1.1× 347 1.1× 178 0.9× 106 0.8× 100 0.9× 26 863
Mariana O. Diniz United Kingdom 17 452 1.4× 252 0.8× 75 0.4× 165 1.3× 188 1.6× 32 743
Susan Holechek United States 8 167 0.5× 139 0.5× 79 0.4× 132 1.1× 150 1.3× 16 505

Countries citing papers authored by Matthias Schroff

Since Specialization
Citations

This map shows the geographic impact of Matthias Schroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Schroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Schroff more than expected).

Fields of papers citing papers by Matthias Schroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Schroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Schroff. The network helps show where Matthias Schroff may publish in the future.

Co-authorship network of co-authors of Matthias Schroff

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Schroff. A scholar is included among the top collaborators of Matthias Schroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Schroff. Matthias Schroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Manuel, et al.. (2016). Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist. Molecular Therapy — Oncolytics. 3. 15023–15023. 5 indexed citations
2.
Schmidt, Manuel, et al.. (2015). Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703. Nucleic Acid Therapeutics. 25(3). 130–140. 38 indexed citations
3.
Schmidt, Manuel, et al.. (2015). Safety, pharmacokinetics and pharmacodynamics from a clinical trial with healthy volunteers using the immunotherapeutic TLR-9 agonist MGN1703. Annals of Oncology. 26. viii5–viii5. 1 indexed citations
4.
Seifert, Karin, et al.. (2015). Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene Therapy. 22(8). 628–635. 18 indexed citations
5.
6.
7.
Weihrauch, Martin R., Heike Richly, Michael S. von Bergwelt‐Baildon, et al.. (2014). Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. European Journal of Cancer. 51(2). 146–156. 54 indexed citations
8.
Grünwald, Viktor, S. Weikert, I G Schmidt-Wolf, et al.. (2014). Aset Study: Final Results of Patients with Locally Recurrent or Metastatic Renal Cell Carcinoma (Rcc) Treated with Mgn1601. Annals of Oncology. 25. iv366–iv366. 2 indexed citations
9.
Kleuss, Christiane, et al.. (2014). Genuine Immunomodulation With dSLIM. Molecular Therapy — Nucleic Acids. 3. e170–e170. 19 indexed citations
10.
Grünwald, Viktor, Steffen Weikert, Stefan Hauser, et al.. (2012). New safety and efficacy data of the ongoing phase I/II study (ASET Study) with an allogeneic tumor vaccine and adjuvant in patients with metastatic renal cell carcinoma.. Journal of Clinical Oncology. 30(5_suppl). 398–398.
11.
12.
Machelska, Halina, Matthias Schroff, Waltraud Binder, et al.. (2009). Peripheral Non-Viral MIDGE Vector-Driven Delivery of β-Endorphin in Inflammatory Pain. Molecular Pain. 5. 72–72. 22 indexed citations
13.
Schakowski, Frank, Marcus Gorschlüter, Peter Buttgereit, et al.. (2007). Minimal size MIDGE vectors improve transgene expression in vivo.. PubMed. 21(1). 17–23. 31 indexed citations
14.
Seifert, Georg, Tillmann Taube, Hagen Graf Einsiedel, et al.. (2006). Brief Communication: Stability and Catalytic Activity of Novel Circular DNAzymes. Nucleosides Nucleotides & Nucleic Acids. 25(7). 785–793. 3 indexed citations
15.
Franke, Jürgen, et al.. (2003). Ballistic CTLA4 and IL-4 gene transfer into the lower lid prolongs orthotopic corneal graft survival in mice. Graefe s Archive for Clinical and Experimental Ophthalmology. 241(11). 921–926. 15 indexed citations
16.
Gomes-Keller, Maria Alice, et al.. (2002). Up-regulation by feline interleukin-4 and down-regulation by feline interferon-gamma of major histocompatibility complex class II on cat B-lymphocytes. Veterinary Immunology and Immunopathology. 88(3-4). 197–208. 6 indexed citations
17.
Schroff, Matthias, et al.. (2002). Influence of ballistic gene transfer on antigen-presenting cells in murine corneas. Graefe s Archive for Clinical and Experimental Ophthalmology. 240(10). 851–859. 16 indexed citations
18.
Schakowski, Frank, Marcus Gorschlüter, Claas Junghans, et al.. (2001). A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA. Molecular Therapy. 3(5). 793–800. 79 indexed citations
19.
Boretti, Felicitas S., Christian M. Leutenegger, Caroline N. Mislin, et al.. (2000). Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS. 14(12). 1749–1757. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mili Gu Breakdown of academic impact, for papers by Tyler Parr Breakdown of academic impact, for papers by Ana Lemos de Matos Breakdown of academic impact, for papers by Hongxing Zhao Breakdown of academic impact, for papers by Agnes E. Hamburger Breakdown of academic impact, for papers by Stephen Pacchione Breakdown of academic impact, for papers by Michael D. Eisenbraun Breakdown of academic impact, for papers by Oliver Höhn Breakdown of academic impact, for papers by Mariana O. Diniz Breakdown of academic impact, for papers by Susan Holechek
Rankless by CCL
2026